<SEC-DOCUMENT>0001193125-25-323798.txt : 20251218
<SEC-HEADER>0001193125-25-323798.hdr.sgml : 20251218
<ACCEPTANCE-DATETIME>20251218083941
ACCESSION NUMBER:		0001193125-25-323798
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20251218
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251218
DATE AS OF CHANGE:		20251218

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ovid Therapeutics Inc.
		CENTRAL INDEX KEY:			0001636651
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				465270895
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38085
		FILM NUMBER:		251581396

	BUSINESS ADDRESS:	
		STREET 1:		441 NINTH AVENUE, 14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10001
		BUSINESS PHONE:		212-776-4381

	MAIL ADDRESS:	
		STREET 1:		441 NINTH AVENUE, 14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10001
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d84904d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ovid="http://www.ovidrx.com/20251218" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-247">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2025-12-18_to_2025-12-18">0001636651</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="ovid-20251218.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2025-12-18_to_2025-12-18"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001636651</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-12-18</xbrli:startDate> <xbrli:endDate>2025-12-18</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-258">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2025-12-18_to_2025-12-18" format="ixt:datemonthdayyearen" id="ixv-259">December&#160;18, 2025</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-260">OVID THERAPEUTICS INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as Specified in Its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2025-12-18_to_2025-12-18" format="ixt-sec:stateprovnameen" id="ixv-261">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-262">001-38085</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-263">46-5270895</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr>
<tr style="font-size:1pt">
<td style="height:7.5pt"/>
<td style="height:7.5pt" colspan="2"/>
<td style="height:7.5pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-264">441 Ninth Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-265">14th Floor</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-266">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2025-12-18_to_2025-12-18" format="ixt-sec:stateprovnameen" id="ixv-267">New York</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;text-align:center"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-268">10001</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Address of Principal Executive Offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s Telephone Number, Including Area Code: <span style="white-space:nowrap"><span style="white-space:nowrap"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-269">646</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-270">661-7661</ix:nonNumeric></span></span></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former Name or Former Address, if Changed Since Last Report)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):</p> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2025-12-18_to_2025-12-18" format="ixt-sec:boolballotbox" id="ixv-271">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2025-12-18_to_2025-12-18" format="ixt-sec:boolballotbox" id="ixv-272">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2025-12-18_to_2025-12-18" format="ixt-sec:boolballotbox" id="ixv-273">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2025-12-18_to_2025-12-18" format="ixt-sec:boolballotbox" id="ixv-274">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;text-align:center"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-275">Common Stock par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-276">OVID</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;text-align:center"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2025-12-18_to_2025-12-18" format="ixt-sec:exchnameen" id="ixv-277">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8201;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;&#8201;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2025-12-18_to_2025-12-18" format="ixt-sec:boolballotbox" id="ixv-278">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div> <div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&#160;18, 2025, Ovid Therapeutics Inc. issued a press release announcing results from its Phase 1 study of OV350. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated herein by reference. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border-spacing:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top;text-align:left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td style="vertical-align:top;text-align:left"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:4%"/>
<td style="width:93%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d84904dex991.htm">Press Release, dated December&#160;18, 2025. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: December&#160;18, 2025 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"><span style="font-weight:bold">OVID THERAPEUTICS INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Jeffrey Rona</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Jeffrey Rona</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Chief Business and Financial Officer</td></tr>
</table></div>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d84904dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g84904g1218105026102.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride
Cotransporter 2 (KCC2), OV350 Intravenous (IV) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">OV350 showed a good safety profile, supporting the advancement of the Company&#8217;s KCC2 portfolio, including
the first oral direct activator, OV4071 </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">There were no treatment-related laboratory findings, no safety findings, and no treatment-related serious adverse
events (SAEs) </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Exploratory quantitative electrophysiology results suggest OV350 had central activity and spectral power
consistent with expected physiological effects of KCC2 modulation; aligned with expected drug exposure in the brain </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pharmacokinetics for OV350 were as predicted, and will inform dosing strategies for future KCC2 development
programs </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">OV4071 (oral) is on track for regulatory submission for a Phase 1/1b clinical trial in Q1 2026
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NEW YORK, December</B><B></B><B>&nbsp;18, 2025</B> &#8211; Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company
developing small molecule medicines to treat brain disorders and symptoms caused by excess neural excitability, today announced results from its Phase 1 study of OV350, the first-ever KCC2 direct activator known to be dosed in humans. The study met
its primary objectives to evaluate safety, tolerability and pharmacokinetics. Results from this intravenous program support the advancement of the Company&#8217;s portfolio of oral KCC2 direct activators into the clinic. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#8220;OV350 is a valuable tool program that supported human safety for drugging KCC2, an entirely new therapeutic target in the brain, which could be a
master switch to curb neural hyperexcitability,&#8221; said Meg Alexander, President and Chief Operating Officer of Ovid Therapeutics. &#8220;The results from this study give us confidence that this new mechanistic class is amenable for further
development and reinforces our decision earlier this year to invest in the development of additional direct activator molecules and formulations for chronic use, including OV4071, the first oral KCC2 direct activator. We expect to submit our
regulatory application for a Phase 1/1b study of OV4071 in Q1 2026 and plan to initiate clinical studies in Q2 2026.&#8221; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Study Design and Key Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OV350 was evaluated in an exploratory randomized, placebo-controlled, single-ascending dose study in 16 healthy participants (six active, two placebo per
cohort). Doses of 50 mg and 100 mg were administered by IV infusion over ten minutes, with pharmacokinetic sampling conducted up to 48 hours post-dosing. In addition to laboratory and clinical results, exploratory quantitative electroencephalography
(qEEG) endpoints were collected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Key findings include: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">At 50 mg and 100 mg doses of OV350, exposure levels achieved expected pharmacologically active concentrations
reinforcing the potential for further clinical development of KCC2 direct activators, including OV4071, which performs with twenty-fold greater potency than OV350 in pharmacodynamic models. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The most frequent treatment-emergent adverse event (AE) associated with OV350 was headache.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nausea and vomiting occurred in a subset of participants who experienced headache. These AEs coincided with the
timing of food intake and are believed to be caused by secondary <FONT STYLE="white-space:nowrap">off-target</FONT> pharmacology unique to OV350. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">There were no treatment-emergent SAEs associated with OV350 and stopping criteria were not met in the study.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The pharmacokinetics were as predicted for all doses. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">qEEG findings supportive of central activity and spectral power relevant for the expected pharmacologic impact of
KCC2 modulation were observed. These effects were contemporaneous with the expected exposure of OV350 in the brain. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Results from the
study will be submitted for a future congress. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Earlier this year, Ovid prioritized and directed its capital resources to accelerate chronic (oral)
formulations of its oral direct activator programs, including OV4071 and OV4041. Accordingly, the Company does not intend to advance OV350 IV further in the clinic. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Advancing a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">First-in-Class</FONT></FONT> Portfolio of Oral KCC2 Direct Activators
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ovid believes the results from OV350 support the advancement of Ovid&#8217;s portfolio of KCC2 direct activators, which contains multiple unique
molecules. Most advanced in the portfolio is development candidate OV4071, an oral direct activator that is twenty-fold more potent than OV350 in pharmacodynamic disease models. Ovid expects to initiate a Phase 1/1b safety and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> clinical study in Q2 2026 for the treatment of psychosis associated with Parkinson&#8217;s disease and Lewy body dementia. These conditions have high unmet
need, validated endpoints, an established regulatory pathway, and traditional atypical antipsychotics are typically contraindicated. Additionally, the Company is planning to characterize the pharmacodynamic effects of OV4071 and relevant mechanisms
in additional neuropsychiatric conditions, such as schizophrenia and psychoses or agitation associated with other neurodegenerative conditions including Alzheimer&#8217;s disease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Concurrent to the clinical translation of OV4071, Ovid is advancing next-generation KCC2 activators from its proprietary library of compounds. These molecules
are designed for oral and injectable formulations. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About KCC2 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KCC2 is a neuron-specific chloride transporter that maintains inhibitory balance in the brain. The cotransporter plays a central role in regulating neuronal
excitability by enabling gamma-aminobutyric acid (GABA) to exert its inhibitory effect. Direct activation of KCC2 represents a differentiated, mechanism-based approach to treating serious neurological and neuropsychiatric conditions in which
neuronal hyperexcitability is central to disease and symptom manifestation. Ovid&#8217;s KCC2 programs are designed to build a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-class</FONT></FONT> franchise targeting
restoration of excitatory/inhibitory balance in the brain, which may offer therapeutic benefit across multiple neurological and neuropsychiatric disorders. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About OV350 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">OV350 is a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">first-in-class,</FONT></FONT> investigational direct activator of KCC2, the neuron-specific chloride transporter that restores inhibitory signaling and helps rebalance hyperexcitable neural circuits. Data from this tool
program is informative in establishing safety, tolerability, pharmacokinetics and pharmacodynamic properties of this new mechanism of action for the brain. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Ovid Therapeutics </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ovid Therapeutics Inc. is a New
York-based biopharmaceutical company dedicated to developing small molecule medicines for brain conditions and symptoms caused by excess neural excitability. Ovid is advancing a pipeline of novel targeted small molecule candidates that modulate the
intrinsic and extrinsic factors involved in neuronal hyperexcitability causative of multiple neurological and neuropsychiatric disorders. Ovid is developing: OV329, a next-generation GABA-aminotransferase inhibitor, as a potential therapy for
treatment-resistant seizures and other undisclosed indications; and is developing OV4071 and other candidates within a library of compounds that directly activate the KCC2 transporter for multiple CNS disorders. For more information about these and
other Ovid research programs, please visit&nbsp;<U>www.ovidrx.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release includes certain disclosures by Ovid that contain &#8220;forward-looking statements&#8221; including, without limitation: statements
regarding the expected timing of initiation, completion, and results and data of Ovid&#8217;s ongoing and planned clinical studies; the potential use and development of OV329, OV4071 and other compounds from Ovid&#8217;s library of direct activators
of KCC2; the potential therapeutic opportunity of OV329, OV4071 and other compounds from Ovid&#8217;s library of direct activators of KCC2; Ovid&#8217;s clinical pipeline strategy and plans for future clinical studies; the expected timing of <FONT
STYLE="white-space:nowrap">IND-enabling</FONT> and formulation efforts for molecules from its KCC2 direct activator library and related regulatory submissions; and other statements that are not historical fact. You can identify forward-looking
statements because they contain words such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potentially,&#8221; and &#8220;will,&#8221; and similar
expressions (as well as other words or expressions referencing future events, conditions or circumstances). Forward-looking statements are based on Ovid&#8217;s current expectations and assumptions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties, risks and changes in circumstances that may differ </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
materially from those contemplated by the forward-looking statements, which are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that
could cause actual results to differ materially from those in the forward-looking statements include, without limitation, uncertainties inherent in the preclinical and clinical development and regulatory approval processes, impediments to
Ovid&#8217;s ability to achieve expected benefits of cost-savings efforts, risks related to Ovid&#8217;s ability to achieve its financial objectives, the risk that Ovid may not be able to realize the intended benefits of its business strategy, or
risks related to Ovid&#8217;s ability to identify business development targets or strategic partners, to enter into strategic transactions on favorable terms, or to consummate and realize the benefits of any business development transactions or
unanticipated or greater than anticipated impacts or delays due to macroeconomic and geopolitical conditions. Additional risks that could cause actual results to differ materially from those in the forward-looking statements are set forth under the
caption &#8220;Risk Factors&#8221; in Ovid&#8217;s most recently filed Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> and Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> filed with the Securities and
Exchange Commission (&#8220;SEC&#8221;), and in subsequent and future filings Ovid makes with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and Ovid assumes no obligation to update any
forward-looking statements contained herein, whether because of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contact </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations&nbsp;&amp; Media </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Victoria Fort </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">VFort@ovidrx.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">202.361.0445 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ovid-20251218.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 12/18/2025 5:05:14 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2025"
  xmlns:ovid="http://www.ovidrx.com/20251218"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.ovidrx.com/20251218"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" namespace="http://xbrl.sec.gov/dei/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" namespace="http://xbrl.sec.gov/naics/2025" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ovid-20251218_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ovid-20251218_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ovid-20251218_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 12/18/2025 5:05:14 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ovid-20251218_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release 2512 Build:20250722.1 -->
<!-- Creation date: 12/18/2025 5:05:14 PM Eastern Time -->
<!-- Copyright (c) 2025 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ovid-20251218.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g84904g1218105026102.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g84904g1218105026102.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "6 3X# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUAA*TU44;Z,&1^$O%VM:]\*M0>QN1_;VDIM$CH'\T*-RD@]25!'U&:YOP/\
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MIN)$5AR(E&%_/)/T(K$^/&A;K?3M?B3F-C:SD?W3RA_/(_&O9E4*H50 H&
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M88]3GEB:92R;+>23('7[JG'XUDCXG^$F9E74)F93A@+*8E?K\G%=A7&^$/\
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M <'!&#R"*7LY6N!TE%<'!XH\6:GI)U_3-%TY]*93+!;2W#"YFB'\0P-JD@9
M-=?H^J0:UH]GJ=L&$-U$LJ!Q@@$=#[BE*#CJP+M%%%2 4444 %%%% !1110
M4444 %%%% !1110!SWC3PM;>+?#=SITRKYVTO;2D<QR <'Z'H?8UR7PCUA]=
M\'7F@:H"\VG,;217/)B8$ 'Z89?P%>G5B:/X4TG0M4U+4=/MS'<:B^^X)<D$
MY)X'89)/XUK&HO9N#^0'E$OP"N?[4*P:W$NFEN"T1,RKZ>A/O^E>SZ7IUOI&
MEVNG6BE;>VB6*,$Y. ,<^]6Z**E>=1)2>P!11160!7&^$/\ D;_&O_80B_\
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MO+#4+'4Y--U*Q+B*X6)904<8965N".!^56)]!%SKVDZO+=.9M.AECVA!B7S
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
:%%% !1110 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001636651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 18,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">OVID THERAPEUTICS INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-5270895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">441 Ninth Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">14th Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">646<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">661-7661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">OVID<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d84904d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d84904d8k.htm">d84904d8k.htm</File>
    <File>ovid-20251218.xsd</File>
    <File>ovid-20251218_lab.xml</File>
    <File>ovid-20251218_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d84904d8k.htm": {
   "nsprefix": "ovid",
   "nsuri": "http://www.ovidrx.com/20251218",
   "dts": {
    "inline": {
     "local": [
      "d84904d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "ovid-20251218.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ovid-20251218_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ovid-20251218_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2025-12-18_to_2025-12-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d84904d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2025-12-18_to_2025-12-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d84904d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.ovidrx.com//20251218/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-25-323798-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-323798-xbrl.zip
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MB5$;& W6QL6C_[BMLR%^S723XV3-9C>5UG<Z0R1"VKEA8M2FCKM'EZC4%Z\
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M<D[F0T90BZVWAZ\/'W&_T!<%ITV@;RS2&:M^H!M>1;Q^L2@*A5C5<B^ZA!7
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MF4<X\<C?4$L! A0#%     @ ]$226_8DKDN&#@   6    T
M ( !     &0X-#DP-&0X:RYH=&U02P$"% ,4    " #T1));4RNO/[,3   '
M40  $               @ &Q#@  9#@T.3 T9&5X.3DQ+FAT;5!+ 0(4 Q0
M   ( /1$DELC?V\W. ,  $4+   1              "  9(B  !O=FED+3(P
M,C4Q,C$X+GAS9%!+ 0(4 Q0    ( /1$DELC_D!N>P8  +A&   5
M      "  ?DE  !O=FED+3(P,C4Q,C$X7VQA8BYX;6Q02P$"% ,4    " #T
M1));##&-P+X$   Z+   %0              @ &G+   ;W9I9"TR,#(U,3(Q
?.%]P<F4N>&UL4$L%!@     %  4 /@$  )@Q      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>d84904d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ovid-20251218.xsd" xlink:type="simple"/>
    <context id="duration_2025-12-18_to_2025-12-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001636651</identifier>
        </entity>
        <period>
            <startDate>2025-12-18</startDate>
            <endDate>2025-12-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-247">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2025-12-18_to_2025-12-18"
      id="Hidden_dei_EntityCentralIndexKey">0001636651</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-258">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-259">2025-12-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-260">OVID THERAPEUTICS INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-261">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-262">001-38085</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-263">46-5270895</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-264">441 Ninth Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-265">14th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-266">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-267">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-268">10001</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-269">646</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-270">661-7661</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-271">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-272">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-273">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-274">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-275">Common Stock par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-276">OVID</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-277">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2025-12-18_to_2025-12-18" id="ixv-278">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
